key: cord-1008344-eayow18i
authors: Oelsner, Elizabeth C; Krishnaswamy, Akshaya; Balte, Pallavi P; Allen, Norrina Bai; Ali, Tauqeer; Anugu, Pramod; Andrews, Howard; Arora, Komal; Asaro, Alyssa; Barr, R Graham; Bertoni, Alain G; Bon, Jessica; Boyle, Rebekah; Chang, Arunee A; Chen, Grace; Coady, Sean; Cole, Shelley A; Coresh, Josef; Cornell, Elaine; Correa, Adolfo; Couper, David; Cushman, Mary; Demmer, Ryan T; Elkind, Mitchell S V; Folsom, Aaron R; Fretts, Amanda M; Gabriel, Kelley Pettee; Gallo, Linda; Gutierrez, Jose; Han, Mei Lan K; Henderson, Joel M; Howard, Virginia J; Isasi, Carmen R; Jacobs Jr, David R; Judd, Suzanne E; Mukaz, Debora Kamin; Kanaya, Alka M; Kandula, Namratha R; Kaplan, Robert; Kinney, Gregory L; Kucharska-Newton, Anna; Lee, Joyce S; Lewis, Cora E; Levine, Deborah A; Levitan, Emily B; Levy, Bruce; Make, Barry; Malloy, Kimberly; Manly, Jennifer J; Mendoza-Puccini, Carolina; Meyer, Katie A; Min, Yuan-I; Moll, Matthew; Moore, Wendy C; Mauger, Dave; Ortega, Victor E; Palta, Priya; Parker, Monica M; Phipatanakul, Wanda; Post, Wendy S; Postow, Lisa; Psaty, Bruce M; Regan, Elizabeth A; Ring, Kimberly; Roger, Véronique L; Rotter, Jerome I; Rundek, Tatjana; Sacco, Ralph L; Schembri, Michael; Schwartz, David A; Seshadri, Sudha; Shikany, James M; Sims, Mario; Hinckley Stukovsky, Karen D; Talavera, Gregory A; Tracy, Russell P; Umans, Jason G; Vasan, Ramachandran S; Watson, Karol; Wenzel, Sally E; Winters, Karen; Woodruff, Prescott G; Xanthakis, Vanessa; Zhang, Ying; Zhang, Yiyi; C4R Investigators, For the
title: Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design
date: 2022-03-12
journal: Am J Epidemiol
DOI: 10.1093/aje/kwac032
sha: 23f9a72a39e33205fc8f1e6cf5a4cea1583d1638
doc_id: 1008344
cord_uid: eayow18i

The Collaborative Cohort of Cohorts for COVID-19 Research (C4R) is a national prospective study of adults comprising 14 established United States (US) prospective cohort studies. Starting as early as 1971, C4R cohorts have collected data on clinical and subclinical diseases and their risk factors, including behavior, cognition, biomarkers, and social determinants of health. C4R links this pre-COVID phenotyping to information on SARS-CoV-2 infection and acute and post-acute COVID-related illness. C4R is largely population-based, has an age range of 18–108 years, and reflects the racial, ethnic, socioeconomic, and geographic diversity of the US. C4R ascertains SARS-CoV-2 infection and COVID-19 illness using standardized questionnaires, ascertainment of COVID-related hospitalizations and deaths, and a SARS-CoV-2 serosurvey via dried blood spots. Master protocols leverage existing robust retention rates for telephone and in-person examinations, and high-quality events surveillance. Extensive pre-pandemic data minimize referral, survival, and recall bias. Data are harmonized with research-quality phenotyping unmatched by clinical and survey-based studies; these will be pooled and shared widely to expedite collaboration and scientific findings. This resource will allow evaluation of risk and resilience factors for COVID-19 severity and outcomes, including post-acute sequelae, and assessment of the social and behavioral impact of the pandemic on long-term trajectories of health.

Fourteen prospective cohorts are collaborating in C4R ( Table 1) . Eight of the cohorts were designed to study cardiovascular disease epidemiology: Atherosclerosis Risk in Communities Differences in Stroke (REGARDS) -were established to study primarily neurological outcomes, including stroke and cognition. NOMAS is a multi-ethnic community study (22) and REGARDS is a biracial (non-Hispanic Black, White) national sample of the continental US that oversampled Black people and those residing in the southeast (23).

These cohorts have collected detailed data on participants' health and behavior for as long as fifty years (Figures 1, 2 The collaborative governance structure for C4R is summarized in Figure 3 . 

Consistent with an ancillary studies model, each cohort is directly responsible for accomplishing its own data collection in accordance with the master protocols and under the supervision of its respective OSMB, Steering Committee, and any other applicable regulatory authorities. To maintain full participation, cohorts were permitted to adapt protocols to cohort-specific needs.

The BCL is responsible for establishing a C4R biorepository of dried blood spots (DBS), plus other biospecimens that may be collected in the future, and for performing and/or coordinating performance of centralized clinical and biomarker assays and serology assays.

Data collection is coordinated centrally at the DCHC. Electronic data collection forms are programmed into REDCap for use or adaptation by the cohort data coordinating centers (DCCs).

Metadata on completion of questionnaires, events ascertainment, and DBS are reported to the DCHC bi-weekly. The DCHC maintains the C4R website, which includes a password-protected investigator section with regular status updates and study materials.

To promote and sustain this broad collaborative effort, C4R PIs invited additional investigators and cohort personnel to participate in sub-committees and working groups. In this manner, C4R

has engaged over 180 investigators to date.

Cohort participants previously consented for in-person, telephone, and/or email contact and for abstraction of medical records. Additional consent for ascertainment of COVID-19 data, including the serosurvey, is obtained according to cohort-specific procedures, including verbal, remote, and traditional written informed consent.

All cohort participants who were alive on March 1 st , 2020 and had not withdrawn consent for cohort participation were considered eligible for enrollment into C4R. Of 72,358 participants who were believed to meet these inclusion criteria, the C4R PIs estimated that 53,143 participants, hereafter described as the C4R target population, were readily available for recruitment into C4R based on recent participation in cohort follow-up calls. The sociodemographic characteristics of participants eligible for C4R (Web Table 2 ) are similar to those of the C4R target population ( Table 2) . Fifty-eight percent of participants in the target population are 65 years or older, and thus at high risk for severe COVID-19. The anticipated sample is racially and ethnically diverse, based on self-report (29) , with approximately 6%

American Indian participants, 2% Asian participants, 26% Black participants, and 20%

Hispanic/Latino participants.

All forty-eight continental states are represented among C4R participants, including rural, suburban, and urban communities (Figure 4) . C4R is being conducted across forty field/clinical centers, many of which are associated with more than one C4R cohort; one cohort with extensive geographic reach, the REGARDS, operates via telephone and in-home exams only Tables 3 and 4 .

As of September 30, 2021, Wave 1 was completed by 13 of the 14 cohorts and wave 2 was initiated in all cohorts (Web Figure 1) . Characteristics of participants completing the Wave 1

Questionnaires as of this date are similar to the target population ( Cohorts use established protocols for checking data completeness and accuracy at the field center and coordinating center levels. Dual data entry for C4R is encouraged but not required since it is not feasible in all settings due to local impediments and COVID-related exigencies.

Ten percent of event reviews are randomly selected for re-review. Reviewers not meeting standards receive regular feedback with recommendations for retraining and/or protocol modifications, as appropriate. Serological assays are repeated on a random 5% sub-sample of blind duplicates.

C4R data defines a spectrum of COVID-19 outcomes, including those listed in Web Table 5 . Table 3) . Harmonization of lung computed tomography is being accomplished using deep learning (70) (71) (72) (73) and other methods, which will be published in separate reports.

The C4R Commons Agreement, modeled on the CHARGE Analysis Commons Consortium Agreement (74), is expediting cross-cohort data harmonization and sharing, as allowed (75).

Following review and approval, cohort-specific agreements permit COVID-19 and pre-pandemic data to be uploaded to the C4R Analysis Commons, which is located on the NHLBI cloud computing platform, BioData Catalyst powered by Seven Bridges. This platform has enterprisegrade compliance and security certification and is HIPAA-compliant and compliant with dbGaP and CLIA security best practices. Nonetheless, no Protected Health Information (PHI) is retained on the C4R Analysis Commons. Participants are assigned a C4R study identifier by the cohortspecific DCC that is distinct from the original cohort participant identifier. Time-to-assessment and time-to-event are calculated as latencies with a random offset.

Access to pooled C4R data is regulated by the C4R publications and presentations (P&P) policy, which is available on the C4R website. Data is made available for analyses on the C4R Analysis Recommendations to address common data issues anticipated for C4R analyses, such as missing data, are developed by the C4R Statistical Sub-Committee and related programming is shareable on the C4R Analysis Commons. Once harmonization and related quality control is completed, C4R common data elements will be transferred as a limited dataset for public access on BioData Catalyst in accord with cohort-specific consents and commitments. C4R constitutes a historic initiative to standardize and expedite data collection by US cohort studies despite major operational and societal challenges. Commitment from cohort PIs with experience in cross-cohort collaboration was critical to expediting study design, protocol development, approval, and deployment. The large scale of data collection was made possible not only by a culture shift toward multi-study collaborative efforts occasioned by experience in CHARGE and TOPMed, but also by the established cohort infrastructure, including sophisticated DCCs that were prepared to implement new protocols rapidly, and experienced and professional clinical staff with longstanding relationships with cohort participants. Differences in data collected by cohort are being reconciled by harmonization, where possible, or else they will be accounted for in analysis plans, in which cohorts without a necessary data element may be excluded. A similar approach is being used with respect to pre-COVID data heterogeneity;

fortunately, many cohorts used similar or identical protocols for data collection in the pre-COVID era, due often to overlapping investigative groups, facilitating harmonization efforts. The challenges of data sharing across fourteen cohorts are well documented (76) and have been surmounted in recent decades by several strategies, including meta-analysis of results generated by cohort-specific DCCs and analyses of pooled cohort data assembled at a single center or on an NHLBI repository. To enhance accessibility, increase security, and expedite high priority analyses, C4R adapted and extended prior data management models by building a cloud-based enclave for assembly, harmonization, and analysis of pooled data.

C4R has certain limitations. Although it includes a diverse, nationwide sample, it was not sampled to be representative of the US population; to some extent, this may be addressed

analytically by weighting approaches. Participation in C4R is voluntary, which may lead to selection biases. Nonetheless, we do not observe major differences in the socio-demographic characteristics of eligible participants compared to participants completing the wave 1 questionnaire, and the preponderance of women in the sample may be explained to some extent by the advanced age of contributing cohorts. Data on acute COVID-19 is sparse in C4R compared to certain EHR resources, but, conversely, data on pre-COVID biomarkers, multiomics, physiology, organ structure, and symptomatology may be richer in C4R and less subject to diagnostic or referral biases. Due to antibody waning, only a subset of self-reported COVID-19 in C4R will be validated by C4R serology, and negative serology will not be suitable to rule • Success of the C4R serosurvey suggests that blood collection by self-collected dried blood spots is feasible and acceptable for remote and, potentially, repeated biosampling and can be integrated into existing and new populationbased cohort studies. Traditional cohort participant-contact methods and procedures work for in-home biosample collection and are critical to success.

• C4R provides a model for cross-cohort collaboration, harmonization, and active data sharing that will promote consortium-based epidemiologic work on biological, social, and epidemiologic questions beyond the COVID-19 pandemic, in alignment with recommendations for strategic transformation of population studies. 

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

COVID-19 as the Leading Cause of Death in the United States

Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

CARDIA: study design, recruitment, and some characteristics of the examined subjects

Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology

Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States

Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos

Design and implementation of the Hispanic Community Health Study/Study of Latinos

Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study

Cardiovascular disease event classification in the Jackson Heart Study: methods and procedures

Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study

Recruitment and retention of US South Asians for an epidemiologic cohort: Experience from the MASALA study

Mediators of Atherosclerosis in South Asians Living in America (MASALA) study: objectives, methods, and cohort description

Multi-Ethnic Study of Atherosclerosis: objectives and design

Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study

Genetic epidemiology of COPD (COPDGene) study design

Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS)

Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age

Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study

The reasons for geographic and racial differences in stroke study: objectives and design

Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts

Harmonization of Respiratory Data From 9 US Population-Based Cohorts: The NHLBI Pooled Cohorts Study

Association Between Blood Pressure and Later-Life Cognition Among Black and White Individuals

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

The Reporting of Race and Ethnicity in Medical and Science Journals: Comments Invited. JAMA. 2021. 30. Multi-Ethnic Study of Atherosclerosis. Oelsner MESA COVID-19 Questionnaire

Behavioral Risk Factor Surveillance System

Health and Retirement Survey

Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale)

A global measure of perceived stress

Reliability and validity of the Women's Health Initiative Insomnia Rating Scale

Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): depression, anxiety, and anger

UCLA Loneliness Scale (Version 3): reliability, validity, and factor structure

The brief resilience scale: assessing the ability to bounce back

The REDCap consortium: Building an international community of software platform partners

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Classifying Chronic Lower Respiratory Disease Events in Epidemiologic Cohort Studies

Racial and regional differences in venous thromboembolism in the United States in 3 cohorts

Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses. medRxiv

Association of Nonobstructive Chronic Bronchitis With Respiratory Health Outcomes in Adults

Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality

FEV1:FVC Thresholds for Defining Chronic Obstructive Pulmonary Disease-Reply

A dyadic growth modeling approach to weight gain and lung function loss: The NHLBI Pooled Cohorts Study

Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study

Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular Events

Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study

A System for Phenotype Harmonization in the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program

Prepared by the McMaster University Evidence-based Practice Center under Contract No. 290-2007-10060-I.) AHRQ Publication No.13-EHC040-EF

Statistical approaches to harmonize data on cognitive measures in systematic reviews are rarely reported

Calibration and validation of an innovative approach for estimating general cognitive performance

Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets

Effects of education and race on cognitive decline: An integrative study of generalizability versus studyspecific results

The Health and Retirement Study Harmonized Cognitive Assessment Protocol Project: Study Design and Methods

A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography

Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS)

Adaptive quantification and longitudinal analysis of pulmonary emphysema with a hidden Markov measure field model

Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung Function

Unsupervised Discovery of Spatially-Informed Lung Texture Patterns for Pulmonary Emphysema: The MESA COPD Study

Emphysema quantification on cardiac CT scans using hidden Markov measure field model: The MESA Lung Study

Unsupervised Domain Adaption With Adversarial Learning (UDAA) for Emphysema Subtyping on Cardiac CT Scans: The Mesa Study

Deep Learning for Health Informatics

Deepcare: A deep dynamic memory model for predictive medicine

Deep Patient: An Unsupervised Representation to Predict the Future of Patients from the Electronic Health Records

-12-10)

Analysis commons, a team approach to discovery in a big-data environment for genetic epidemiology

NIH Tribal Consultation Report: NIH Draft Policy for Data Management and Sharing

Innovation in Genomic Data Sharing at the NIH

Strategic transformation of population studies: recommendations of the working group on epidemiology and population sciences from the National Heart, Lung, and Blood Advisory Council and Board of External Experts

DLCO = diffusing capacity of the lung for carbon monoxide

GWAS = genome-wide association study

MRI = magnetic resonance imaging; neurocog = neurocognitive

Cohort of Cohorts for COVID-19 Research

CARDIA = Coronary Artery Risk Development in Young Adults

HCHS/SOL = Hispanic Community Health Study/Study of Latinos

PrePF = Prevent Pulmonary Fibrosis

REGARDS = REasons for Geographic and Racial Differences in Stroke

SPIROMICS = Subpopulations and Intermediate Outcome Measures in COPD Study

Heart Study a If the most recent exam was prior to 2010, data are not included

Tauqueer Ali, Nori Allen, Howard Andrews, Pramod Anugu, Komal Arora, Alex Arynchyn, Alyssa Asaro, Pallavi P. Balte, Mike Bancks, R. Graham Barr, Lori Bateman, Alain Bertoni, Alexander G. Bick, Eugene Bleecker, David Bluemke, Rebekah Boyle, Matt Budoff, Jonathan Cardwell, Jeffrey

A full list of participating REGARDS investigators and institutions can be found at: https://www.uab.edu/soph/regardsstudy/